FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q2 2020

Top Holdings119 positions

Checking export access…
Activity:

IQVIA Holdings Inc.

3.8M$538.6M4.3%$117.85+16.69%
7 qtrssince 2018-Q4
Increased
58

FIDELITY NATL INFORMATION SV

3.6M$481.4M3.9%$102.06+14.48%
7 qtrssince 2018-Q4
Decreased
0
1.4M$456M3.6%——
4 qtrssince 2019-Q3
Decreased
0

CENTENE CORP DEL

7M$444.9M3.6%$57.71+8.46%
2 qtrssince 2020-Q1
Decreased
0

AbbVie Inc.

4.2M$407.4M3.3%$62.11+23.84%
4 qtrssince 2019-Q3
Increased
59

Thermo Fisher Scientific Inc

1.1M$387.5M3.1%$306.34+16.30%
3 qtrssince 2019-Q4
Decreased
0

CHARTER COMMUNICATIONS INC N

755,015$385.1M3.1%$304.08+67.46%
7 qtrssince 2018-Q4
Increased
60

T-MOBILE US INC

3.5M$360.1M2.9%$102.370.00%
1 qtr
New
80

Visa Inc

1.8M$347.6M2.8%$139.11+32.72%
7 qtrssince 2018-Q4
Increased
54

AON PLC

1.7M$331.4M2.7%$184.210.00%
1 qtr
New
80

ANTHEM INC

1.3M$328.7M2.6%$246.79-2.47%
7 qtrssince 2018-Q4
Unchanged
0

Alphabet Inc.

221,050$312.5M2.5%$56.30+24.36%
7 qtrssince 2018-Q4
Decreased
0

Microsoft Corp.

1.5M$311M2.5%$116.22+66.12%
7 qtrssince 2018-Q4
Decreased
0

Meta Platforms Inc

1.4M$308.5M2.5%$162.10+35.17%
7 qtrssince 2018-Q4
Increased
65
3.9M$295.2M2.4%——
7 qtrssince 2018-Q4
Decreased
0

SALESFORCE COM INC

1.5M$285.8M2.3%$160.49+12.86%
3 qtrssince 2019-Q4
Decreased
0
WUBAWUBADelisted
ADR

58 COM INC

5M$267.8M2.1%——
1 qtr
New
80

The Sherwin-Williams Company

447,987$258.9M2.1%$138.25+31.81%
6 qtrssince 2019-Q1
Decreased
0

WABTEC

4.3M$249M2.0%$63.37-12.31%
7 qtrssince 2018-Q4
Decreased
0

EXELIXIS INC

10.3M$243.3M1.9%$18.26+30.03%
7 qtrssince 2018-Q4
Increased
50
$12.5B
AUM
119
Positions
Q2 2020
Filing
HI score · 1.5/5
Quarterly 13F Value Change
+6%Q1'19$12.1B+18%Q2'19$14.3B-15%Q3'19$12.2B+6%Q4'19$13B-16%Q1'20$10.9B+14%Q2'20$12.4B
Activity profile
$ moved · Q2'20
New33%Increased16%Decreased13%Exited38%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.0 quarters
<1Q29%1-4Q27%1-2Y44%2Y+0%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $12.5B across 119 positions as of Q2 2020. Top holdings: IQV (4.3%), FIS (3.9%), HNIB (3.6%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1.5/5.0.

Q2 2020 Summary

Active quarter - 36 new positions, 19 exits, 29 increased. Top move: TMUS (NEW, conviction 80). Portfolio: $12.5B across 119 positions.

Top holdings by portfolio weight

Total AUM$12B
IQV4.31%
FIS3.85%
HNIB3.65%
CNC3.56%
ABBV3.26%
TMO3.10%
CHTR3.08%
TMUS2.88%
V2.78%
AON2.65%
Other2.63%

Portfolio allocation by GICS sector

Sectors9
Healthcare36.60%
Unknown21.83%
Communication Services13.08%
Technology10.82%
Financial Services7.98%
Industrials4.11%
Basic Materials2.20%
Consumer Cyclical1.70%
Real Estate1.70%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown, Communication Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L48
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBoston Scientific Corporation
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used